{
    "code": "60001076",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001076",
    "time": "2020-04-17 03:21:19",
    "許可證字號": "衛部菌疫輸字第001076號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/06\/25",
    "發證日期": "107\/06\/25",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000107604",
    "中文品名": "立美西膚皮下注射劑210毫克",
    "英文品名": "LUMICEF Subcutaneous Injection 210mg Syringe",
    "適應症": "治療適合接受全身性治療的中至重度斑塊性乾癬成人病人，治療適合接受全身性治療的膿疱性乾癬之成人病人",
    "劑型": "243凍晶注射劑",
    "包裝": "玻璃預充填式針筒裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "112\/06\/25",
    "主成分略述": "brodalumab",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5F免除銜接性試驗",
    "申請商名稱": "1902001100  台灣協和麒麟股份有限公司",
    "申請商地址": "台北市中山區中山北路二段68號9樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT9099000  PATHEON ITALIA S.P.A.",
            "製造廠廠址": "VIALE G.B. STUCCHI, 110-20900 MONZA (MB), ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6101111420  瑪里士實業有限公司",
            "製造廠廠址": "臺北市內湖區舊宗路二段121巷30號2樓、32號2樓、2樓之1及36號4樓",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FJP1009000  KYOWA KIRIN CO., LTD.",
            "製造廠廠址": "1-9-2 OTEMACHI, CHIYODA-KU, TOKYO, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "委託製造者"
        },
        {
            "製造廠名稱": "FJP9458900  KYOWA KIRIN CO., LTD. TAKASAKI PLANT",
            "製造廠廠址": "100-1 HAGIWARA-MACHI, TAKASAKISHI, GUNMAN, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0866000  IMMUNEX RHODE ISLAND CORPORATION",
            "製造廠廠址": "40 TECHNOLOGY WAY, WEST GREENWICH RHODE ISLAND 02817, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200090200",
            "成分名稱": "brodalumab",
            "含量描述": "",
            "含量": "210.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[藥物外觀圖檔] Lumicef_2018SEP-109-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "[Package Insert]+Lumicef_V3-109-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=003&Type=9"
        },
        {
            "title": "[Package+Insert]+Lumicef_V2-108-01-21-108-02-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=002&Type=9"
        },
        {
            "title": "[Package Insert] Lumicef_2018JUL_V1-107-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=001&Type=9"
        },
        {
            "title": "[外盒圖檔] Lumicef_202002-109-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=003&Type=8"
        },
        {
            "title": "[藥物外觀圖檔] Lumicef_2018SEP-107-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=002&Type=8"
        },
        {
            "title": "[外盒圖檔] Lumicef_2018SEP-107-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001076&Seq=001&Type=8"
        }
    ]
}